← all drugs
Disopyramide Phosphate Capsule, Extended Release
being discontinued · Cardiovascular · Snapshot: 2026-10-09
- Manufacturers listed
- Pfizer Inc.
- Machine-readable
- JSON for this drug
Presentations (2)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Norpace CR, Capsule, Extended Release, 100 mg (NDC 0025-2732-31) | Pfizer Inc. | unknown | 08/24/2026 |
| Norpace CR, Capsule, Extended Release, 150 mg (NDC 0025-2742-31) | Pfizer Inc. | unknown | 08/24/2026 |
History
Daily tracking of this drug began 2026-08-26.
- 2026-08-26 — Disopyramide Phosphate Capsule, Extended Release appeared on the FDA shortage list (being discontinued)
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.